Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2003
07/15/2003US6593323 Benzimidazole compounds and drugs containing the same
07/15/2003US6593322 Compounds and methods for modulation of estrogen receptors
07/15/2003US6593313 Co-administration of a prostaglandin and an androgenic agent in the treatment of female sexual dysfunction
07/15/2003US6593291 Inhibition of endothelial cell proliferation inhibits neovascularization
07/15/2003US6593108 Nucleic acid molecule encoding a melanin-concentrating hormone receptor 2 polypeptide
07/15/2003US6592911 (−)-Olivil as antioxidant which is obtained from a new natural source namely Stereospermum personatum
07/15/2003US6592910 Methods of treating clinical diseases with isoflavones
07/15/2003US6592902 Controlled release eplerenone compositions
07/15/2003US6592894 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
07/15/2003US6592862 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
07/15/2003US6592618 In vitro modification of cardiac valvular xenografts
07/15/2003CA2238465C Triaromatic compounds, compositions containing them and uses
07/15/2003CA2180843C Pyridine modulators of acetylcholine receptors
07/15/2003CA2086221C Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agent
07/15/2003CA2067408C 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors
07/14/2003WO2003059878A2 Thieno (3, 2-b) pyridones as antiviral compounds
07/14/2003CA2472960A1 Thieno (3, 2-b) pyridones as antiviral compounds
07/10/2003WO2003056010A2 An antisense strategy to modulate estrogen receptor response (er. alpha. and/or er. beta.)
07/10/2003WO2003055983A2 Targeted retrograde gene delivery to motor neurons
07/10/2003WO2003055916A2 Adiponectin fragments and conjugates
07/10/2003WO2003055915A2 Human netrin receptor and uses thereof
07/10/2003WO2003055913A2 Secreted protein
07/10/2003WO2003055912A2 Secreted proteins
07/10/2003WO2003055911A2 Cystine-knot fold protein
07/10/2003WO2003055910A1 Beta-amyloid binding factors and inhibitors thereof
07/10/2003WO2003055901A1 Novel peptide sy
07/10/2003WO2003055884A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
07/10/2003WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
07/10/2003WO2003055881A1 Pyrido(2,1-a)isoquinoline derivatives as dpp-iv inhibitors
07/10/2003WO2003055880A2 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same
07/10/2003WO2003055877A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
07/10/2003WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
07/10/2003WO2003055865A1 Quinazolinone derivative
07/10/2003WO2003055863A1 Novel alkansulfonamides as endothelin antagonists
07/10/2003WO2003055856A2 BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE)
07/10/2003WO2003055848A2 Urea derivatives as vr1- antagonists
07/10/2003WO2003055847A1 Carboxylic acid derivative
07/10/2003WO2003055523A1 Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes
07/10/2003WO2003055519A1 Medicinal agent and method for curing diseases accompanied with vascular dystonia
07/10/2003WO2003055516A1 Pecam-1 modulation
07/10/2003WO2003055505A2 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders
07/10/2003WO2003055495A1 ORAL PHARMACEUTICAL PRODUCTS CONTAINING 17β-ESTRADIOL-3-LOWER ALKANOATE, METHOD OF ADMINISTERING THE SAME AND PROCESS OF PREPARATION
07/10/2003WO2003055492A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
07/10/2003WO2003055487A1 METHOD OF CONTROLLING DAMAGE MEDIATED BY α, β- UNSATURATED ALDEHYDES
07/10/2003WO2003055485A1 Dosing regimen for ppar-gamma activators
07/10/2003WO2003055484A1 Urea derivatives
07/10/2003WO2003055482A1 Amide derivatives as gk activators
07/10/2003WO2003055481A1 Organ fibrosis inhibitors
07/10/2003WO2003055477A1 Method for the treatment of mc receptor related disorders with a chelate and/or a chelator
07/10/2003WO2003055474A1 Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine
07/10/2003WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme
07/10/2003WO2003055440A2 Compositions and methods for the treatement of immune related diseases
07/10/2003WO2003055335A1 Modified methionine rich food products and process for their manufacture
07/10/2003WO2003043987A3 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
07/10/2003WO2003035670A3 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
07/10/2003WO2003004511A3 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
07/10/2003WO2002101392A3 Methods for treating disorders of the nervous and reproductive systems
07/10/2003WO2002096937A3 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
07/10/2003WO2002079778A3 In vivo delivery methods and compositions
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002018581A3 G-protein coupled receptors
07/10/2003WO2002009761A9 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
07/10/2003WO2002005813A3 Method for preventing and/or decreasing amyloid production with polycyclic compounds
07/10/2003US20030130523 Delivers more oxygen to hypoxic and ischemic tissues by reducing the oxygen affinity of hemoglobin in whole blood; substituted phenylacetanilides containing carboxyl group(s)
07/10/2003US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
07/10/2003US20030130508 3,5-bis(trifluoromethyl)phenylmethylene-substituted derivatives of nicotamide or pyridinylaminocarbonyl compounds; used to treat disorders of the central nervous system such as anxiety, depression and psychosis.
07/10/2003US20030130355 Serotonin/noradrenaline reuptake inhibitors (N-(1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl)-N,N-dimethylamine; dietetics; side effects reduction
07/10/2003US20030130339 Such as (E)-2-pyridineethenyl-4-fluorobenzyl sulfone; antitumor/anticancer agents
07/10/2003US20030130330 Materials and methods for the treatment of hypertension and angina
07/10/2003US20030130329 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
07/10/2003US20030130325 Substituted tryptophan derivatives
07/10/2003US20030130323 Anorectic agents
07/10/2003US20030130321 Method of resolving amlodipine racemate
07/10/2003US20030130309 Antiinflammatory agents; rheumatic diseases
07/10/2003US20030130303 Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal
07/10/2003US20030130296 FXR NR1H4 nuclear receptor binding compounds
07/10/2003US20030130295 Substituted 2-aminoacetamides and the use thereof
07/10/2003US20030130289 Inhibitors of glycogen synthase kinase 3
07/10/2003US20030130286 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents
07/10/2003US20030130285 Controlling cell differentiation, cell proliferation
07/10/2003US20030130283 CRF receptor antagonists and methods relating thereto
07/10/2003US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
07/10/2003US20030130279 Hyperglycemic agents; dietetics; cardiovascular disorders; immunology modulation; osteoporosis; cognition activators
07/10/2003US20030130277 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
07/10/2003US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
07/10/2003US20030130261 Central nervous system disorders; psychological disorders; inflammatory bowel disorders
07/10/2003US20030130260 Aryl fused azapolycyclic compounds
07/10/2003US20030130257 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
07/10/2003US20030130255 Pyridoquinoxaline antivirals
07/10/2003US20030130254 Respiratory system disorders; antihistamines; antiarthritic agents
07/10/2003US20030130244 Mixture of estrogen, androgen and anticholinergic agent
07/10/2003US20030130238 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/10/2003US20030130237 Lysophosphatidic acid receptor antagonist; anticancer agents
07/10/2003US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
07/10/2003US20030130235 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
07/10/2003US20030130216 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease(cad) for treating cardiac disease
07/10/2003US20030130209 Method of treatment of myocardial infarction
07/10/2003US20030130203 Sleep disorders
07/10/2003US20030130201 Mixture with ascorbic acid, proline and lysine
1 ... 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 ... 1595